These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24128101)

  • 1. Assessment of new drugs in a tertiary hospital using a standardized tool.
    González-Bueno J; Chamorro-de-Vega E; Alfaro-Lara ER; Galván-Banqueri M; Santos-Ramos B
    Farm Hosp; 2013; 37(5):388-93. PubMed ID: 24128101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlling financial variables--changing prescribing patterns.
    Abramowitz PW
    Am J Hosp Pharm; 1984 Mar; 41(3):503-15. PubMed ID: 6367444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug approval processes in Australian Paediatric Hospitals.
    Sinha YK; Craig JC; Barclay P; Taitz J; South M; Coulthard K; Pearson C; Erickson S; Brien JE
    Arch Dis Child; 2010 Sep; 95(9):739-44. PubMed ID: 20584852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic interchange of drugs not included in the hospitaĺs pharmacotherapeutic guide: a quality program].
    Navarro de Lara S; Font Noguera I; Lerma Gaude V; López Briz E; Martínez Pascual MJ; Poveda Andrés JL
    Farm Hosp; 2004; 28(4):266-74. PubMed ID: 15369437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital formularies: organizational aspects and supplementary components.
    Rucker TD; Visconti JA
    Am J Hosp Pharm; 1976 Sep; 33(9):912-7. PubMed ID: 984056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges of a P & T Committee in a community teaching hospital.
    Cooke DH; Kessler J
    Hosp Formul; 1990 Aug; 25(8):878-82, 886. PubMed ID: 10105706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating a restrictive formulary system by assessing nonformulary-drug requests.
    Green JA; Chawla AK; Fong PA
    Am J Hosp Pharm; 1985 Jul; 42(7):1537-41. PubMed ID: 4025350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceuticals in Australia: priorities in a teaching hospital.
    Kearney BJ
    Physician Exec; 1993; 19(5):63-7. PubMed ID: 10130953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion of innovation II: Formulary acceptance rates of new drugs in teaching and non-teaching British Columbia hospitals--a drug development perspective.
    D'Sa MM; Hill DS; Stratton TP
    Can J Hosp Pharm; 1995 Feb; 48(1):7-15. PubMed ID: 10141063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for therapeutic interchange-2004.
    Gray T; Bertch K; Galt K; Gonyeau M; Karpiuk E; Oyen L; Sudekum MJ; Vermeulen LC;
    Pharmacotherapy; 2005 Nov; 25(11):1666-80. PubMed ID: 16232030
    [No Abstract]   [Full Text] [Related]  

  • 11. [Analysis of the selection process for new drugs in a tertiary hospital 2004-2007].
    Alfaro-Lara ER; Galván-Banqueri M; Prado-Mel E; Santos-Ramos B; Varela-Aguilar JM; Torelló-Iserte J; Castellano Zurera MM; Bautista Paloma FJ
    Farm Hosp; 2010; 34(2):76-84. PubMed ID: 20304366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion of innovation I: Formulary acceptance rates of new drugs in teaching and non-teaching British Columbia hospitals--a hospital pharmacy perspective.
    D'Sa MM; Hill DS; Stratton TP
    Can J Hosp Pharm; 1994 Dec; 47(6):254-60. PubMed ID: 10139270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Access to new cardiovascular therapies in Canadian hospitals: a national survey of the formulary process.
    Shalansky SJ; Virk R; Ackman M; Jackevicius C; Kertland H; Tsuyuki R; Humphries K;
    Can J Cardiol; 2003 Feb; 19(2):173-9. PubMed ID: 12601443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulary evaluation of third-generation cephalosporins using decision analysis.
    Cano SB; Fujita NK
    Am J Hosp Pharm; 1988 Mar; 45(3):566-9. PubMed ID: 3285673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of drug therapy prescribed in special situations at hospital.
    González-Morcillo G; Calderón-Hernanz B; Rodríguez-Camacho JM
    Farm Hosp; 2020 Oct; 44(6):272-278. PubMed ID: 33156745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues in formulary management: therapeutic interchange. Establishing guidelines: roundtable discussion, Part 1.
    Mahoney C; Cichon M; Cromer M; DeGiulio H; Renshaw B; Rodriguez FA; Wert D
    Hosp Formul; 1992 Oct; 27 Suppl 2():4-8. PubMed ID: 10122036
    [No Abstract]   [Full Text] [Related]  

  • 17. Formularies: the role of pharmacy-and-therapeutics (P&T) committees.
    Summers KH; Szeinbach SL
    Clin Ther; 1993; 15(2):433-41; discussion 432. PubMed ID: 8519049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulary decision making: identifying factors that influence P&T committee drug evaluations.
    Segal R; Pathak DS
    Hosp Formul; 1988 Feb; 23(2):174-8. PubMed ID: 10286022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multidisciplinary process to determine, communicate, and manage an antibiotic formulary.
    Cook AA; Sanchez ML
    Hosp Pharm; 1992 Oct; 27(10):867-9, 872-4, 882. PubMed ID: 10121423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Issues in formulary management: therapeutic interchange. The value, cost, and quality of therapeutic interchange.
    Mahoney CD
    Hosp Formul; 1992 Oct; 27 Suppl 2():2-3. PubMed ID: 10122035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.